• 1
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359362.
  • 2
    Alter MJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. Detection of antibodies to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 14941500.
  • 3
    Tremolada F, Casarin C, Albert A, Drago C, Tagger A, Ribero ML, Realdi G. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis. J Hepatol 1992; 16: 273281.
  • 4
    Viladomiu L, Genescà J, Estebàn JI, Allende H, Gonzales Alopez TJ, Esteban R. et al. Interpheron-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial. Hepatology 1992; 15: 767769.
  • 5
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tommasini MA, Dioguardi, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; i: 10061008.
  • 6
    Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M. et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii: 10041006.
  • 7
    Caporaso N, Romano M, Marmo R, de Sio I, Morisco F, Minerva A, Coltorti M. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with liver cirrhosis. J Hepatol 1991; 12: 367371.
  • 8
    Ken MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4: 136146.
  • 9
    Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA. et al. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 1989; 59: 11451156.
  • 10
    Geller SA, Nichols WS, Kim S, Tolmachoff T, Lee S, Dycaico MJ, Felts K. et al. Hepatocarcinogenesis is the sequel to hepatitis in Z#2 α1-antitrypsin transgenic mice: histopathological and DNA ploidy studies. Hepatology 1994; 19: 389397.
  • 11
    Humbel RE. Insulin-like growth factors I and II. Eur J Biochem 1990; 190: 445462.
  • 12
    Zarrilli R, Bruni CB, Riccio A. Multiple levels of control of the insulin-like growth factor gene expression. Mol Cell Endocrinol 1994; 101: R1R14.
  • 13
    DeChiara TM, Esfradiatis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 1990; 345: 7880.
  • 14
    Liu J-P, Baker J, Perkins AS, Robertson EJ, Esfradiatis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (IGFlr). Cell 1993; 75: 5972.
  • 15
    Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestly L, Scott J, Rail LB. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984; 311: 775778.
  • 16
    De Pagter-Holtuizen P, Jansen M, van Schaik FMA, van der Kammen R, Oosterwijk C, Van den Brande JL, Sussenbach JS. The human insulin-like growth factor II gene contains two development-specific promoters. FEES Lett 1987; 214: 259264.
  • 17
    De Pagter-Holtuizen P, Jansen M, van der Kammen R, van Schaik FMA, Sussenbach JS. Differential expression of the human insulin-like growth factor II gene Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II associated protein. Biochim Biophys Acta 1988; 950: 282295.
  • 18
    Vu TH, Hoffman AR. Promoter-specific imprinting status of the human insulin-like growth factor II gene. Nature 1994; 371: 714717.
  • 19
    Baserga R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 1995; 55: 249252.
  • 20
    Zarrilli R, Pignata S, Romano M, Gravina A, Casola S, Bruni CB, Acquaviva AM. Expression of insulin-like growth factor II (IGF-II) and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. Cell Growth Diff 1994; 5: 10851091.
  • 21
    Christofori G, Naik P, Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 1994; 369: 414418.
  • 22
    Norstedt G, Levinovitz A, Moller C, Eriksson LC, Andersson G. Expression of insulin-like growth factor I (IGF-I) and IGF-II mRNA during hepatic development, proliferation and carcinogenesis in the rat. Carcinogenesis 1988; 9: 209213.
  • 23
    Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE. Reactivation of insulin-like Growth Factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1992; 52: 25492556.
  • 24
    Casola S, Ungaro P, Pedone PV, Lazzaro D, Fattori E, Ciliberto G, Zarrilli R. et al. Loss of eterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas. Oncogene 1995; 11: 711721.
  • 25
    Yang D, Rogler CE. Analysis of insulin-like growth factor II (IGF-II) expression in neoplastic nodules and hepatocellular carcinomas of woodchucks utilizing in situ hybridization and immunocytochemistry. Carcinogenesis 1991; 12: 18931901.
  • 26
    Yang D, Alt E, Rogler CE. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers. Cancer Res 1993; 53: 20202027.
  • 27
    Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R. et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J Biol Chem 1994; 269: 1377913784.
  • 28
    Cariani E, Lasserre C, Seurin D, Hamelin B, Kemeny F, Franco D, Czech MP. et al. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res 1988; 48: 68446849.
  • 29
    Schneid E, Holthuizen PE, Sussenbach JS. Differential promoter activation in two human insulin-like growth factor II producing tumor cell lines. Endocrinology 1993; 132: 11451150.
  • 30
    Travail S, Ku DH, Rizzo MG, Ottavio L, Baserga R, Calabretta B. Structure of the human gene for the proliferating cell nuclear antigen. J Biol Chem 1989; 264: 74667472.
  • 31
    Nakamura T, Hayama M, Sakai T, Hotchi M, Tanaka E. Proliferative activity of hepatocytes in chronic viral hepatitis as revealed by immunohistochemistry for proliferating cell nuclear antigen. Hum Pathol 1993; 24: 750753.
  • 32
    Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 15131520.
  • 33
    The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994; 20: 1520.
  • 34
    Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW. et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431435.
  • 35
    Edmonson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462503.
  • 36
    Chomczyinski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chlorofrom extraction. Anal Biochem 1987; 162: 156159.
  • 37
    Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Volume 1 (chapter 7). 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
  • 38
    Pedone PV, Cosma MP, Ungaro P, Colantuoni V, Bruni CB, Zarrilli R, Riccio A. Parental imprinting of rat insulin-like growth factor II gene promoters is coordinately regulated. J Biol Chem 1994; 269: 2397023975.
  • 39
    Tso JY, Sun XH, Kao T, Reece S, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNA: genomic complexity and moleculare evolution of the gene. Nucleic Acids Res 1985; 13: 24852502.
  • 40
    Huang S-N, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995; 21: 620626.
  • 41
    D'Arville CN, Nouri-Aria KT, Johnson P, Williams, R. Regulation of insulin-like growth factor II gene expression by hepatitis B virus in hepatocellular carcinoma. Hepatology 1990; 13: 310315.
  • 42
    Lamas E, Le Bail B, Housset C, Boucher O, Brechot C. Localization of insulin-like growth factor-II and hepatitis B virus mRNA and proteins in human hepatocellular carcinomas. Lab Invest 1991; 64: 98104.
  • 43
    Su Q, Liu YF, Zhang JF, Zhang SX, Li DF, Yang JJ. Expression of insulin-like growth factor II in hepatitis B. cirrhosis and hepatocellular carcinoma: its relationship with hepatitis B virus antigen expression. Hepatology 1994; 20: 788799.
  • 44
    Lamas E, Zindy F, Seurin D, Guguen-Guillouzo C, Brechot C. Expression of insulin-like growth factor II and receptors for insulin-like growth factor II. insulin-like growth factor I and insulin in isolated and cultured rat hepatocytes. Hepatology 1991; 13: 936940.
  • 45
    Verspohl EJ, Maddux AB, Goldfine I. Insulin and insulin-like growth factor I regulate the same biological functions in Hep G2 cells via their own specific receptors. J Clin Endocrinol Metab 1988; 67: 169174.
  • 46
    Vogelstein B, Kinzler KW. The multistep nature of cancer. Trend Genet 1993; 9: 138141.
  • 47
    Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K, Maeda S. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 1994; 54: 231235.
  • 48
    Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M. et al. Amplification and overexpression of the cyclin Dl gene in aggressive human hepatocellular carcinoma. Cancer Res 1994; 54: 31073110.
  • 49
    Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991; 324: 933940.
  • 50
    Park BC, Huh MH, Seo JH. Differential expression of transforming growth factor α and insulin-like growth factor II in chronic active hepatitis B. cirrhosis and hepatocellular carcinoma. J Hepatol 1995; 22: 286294.